$15 Bn Structural Heart Devices Market - Global Forecast to 2023

12/19/2018, 11:30 AM (Source: GlobeNewswire)

Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) -- The "Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%.

The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market.

The replacement procedures segment is projected to register the highest CAGR during the forecast period.

Based on procedure, the structural heart devices market is segmented replacement procedures and repair procedures. The replacement procedures segment is further segmented into TAVR procedures and SAVR procedures, while the repair procedures segment is subdivided into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures. The replacement procedures segment is expected to register the highest CAGR during the forecast period. This can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.

Asia Pacific to witness the highest growth during the forecast period.

The structural heart devices market in the Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising geriatric population, favorable reimbursement scenario, increasing regulatory approvals, the presence of a large target patient population, increasing healthcare expenditure, implementation of government-funded insurance schemes, and the growing medical tourism industry in several APAC countries are expected to drive the growth of the Asia Pacific structural heart devices market.

The major players operating in the structural heart devices market are Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK).

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Data Estimation and Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Structural Heart Devices: Market Overview
4.2 Geographic Analysis: Structural Heart Devices Market, By Repair Procedures
4.3 Structural Heart Devices Market, By Procedure, 2018 vs 2023
4.4 Structural Heart Devices Market, By Product, 2018 vs 2023
4.5 Geographic Snapshot of the Structural Heart Devices Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Structural Heart Diseases
5.2.1.2 Regulatory Approvals of New and Advanced Structural Heart Devices
5.2.1.2.1 Product Approvals for Medtronic
5.2.1.2.2 Product Approvals for Edwards Lifesciences Corporation
5.2.1.2.3 Product Approvals for Abbott Laboratories
5.2.1.2.4 Product Approvals for Livanova
5.2.1.2.5 Product Approvals for Micro Interventional Devices
5.2.1.3 Favorable Reimbursement Scenario
5.2.1.4 Increasing Awareness About Structural Heart Diseases
5.2.2 Restraints
5.2.2.1 Low Affordability and Inaccessibility of Cardiac Surgeries in Developing Countries
5.2.3 Opportunities
5.2.3.1 Percutaneous Interventions, Approval of TAVR for Extended Indications
5.2.3.2 Emerging Countries
5.2.3.3 Emergence of Tissue-Engineered Heart Valves
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Personnel

6 Structural Heart Devices Market, By Product
6.1 Introduction
6.2 Heart Valve Devices
6.2.1 Transcatheter Heart Valves
6.2.2 Surgical Heart Valves
6.2.2.1 Tissue Heart Valves
6.2.2.2 Mechanical Heart Valves
6.3 Occluders & Delivery Systems
6.4 Annuloplasty Rings
6.5 Accessories
6.6 Other Devices

7 Structural Heart Devices Market, By Procedure
7.1 Introduction
7.1.1 Replacement Procedures
7.1.1.1 TAVR Procedures
7.1.1.2 Savr Procedures
7.1.2 Repair Procedures
7.1.2.1 Closure Procedures
7.1.2.2 Annuloplasty
7.1.2.3 Valvuloplasty
7.1.2.4 TMVR Procedures

8 Structural Heart Devices Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 Italy
8.3.3 UK
8.3.4 France
8.3.5 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.2 Market Ranking Analysis of Key Players, 2017
9.3 Competitive Scenario
9.3.1 Product Launches and Approvals
9.3.2 Acquisitions
9.3.3 Expansions
9.3.4 Partnerships and Agreements

10 Company Profiles
10.1 Edwards Lifesciences Corporation
10.2 Medtronic
10.3 Abbott
10.4 Boston Scientific Corporation
10.5 Livanova
10.6 Lepu Medical Technology
10.7 Cryolife
10.8 Micro Interventional Devices
10.9 Braile Biomdica
10.10 TTK Healthcare (A TTK Group Company)

For more information about this report visit https://www.researchandmarkets.com/research/n4dbgg/15_bn_structural?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Devices

22157.jpg

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.